| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.0093 | 1 |